PDCD1LG2 and esophageal squamous cell carcinoma: A recent study demonstrated the profound influence on the expression of PD-L1 and PD-L2 by chemotherapeutic agents in esophageal squamous cell carcinoma (ESCC) (32), which implied one-time evaluation of PD-L1 might not be sufficient to predict the efficacy of ICIs.